Estrogen receptor β expression induces changes in the microRNA pool in human colon cancer cells

Carcinogenesis

Volumn 34, Issue 7, 2013, Pages 1431-1441

  Edvardsson, Karin ^a,b   Nguyen Vu, Trang ^a   Kalasekar, Sharanya M ^a   Pontén, Fredrik ^c   Gustafsson, Jan Åke ^a,b   Williams, Cecilia ^a  

^a University of Houston   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR BETA; MICRORNA; MICRORNA 10B; MICRORNA 17; MICRORNA 192; MICRORNA 200A; MICRORNA 200B; MICRORNA 205; MICRORNA 20A; MICRORNA 20B; MICRORNA 221; MICRORNA 9; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; ESTROGEN BINDING; ESTROGEN RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

CADHERINS; CELL DEATH; CELL MOVEMENT; CELL SHAPE; COLONIC NEOPLASMS; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN RECEPTOR BETA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MICRORNAS; NUCLEAR RECEPTOR COACTIVATOR 3; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84880285292     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt067     Document Type: Article

References (92)

1. Ferlay, J.S.H et al. (2008) GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide. IARC Scientific Publications No. 10. International Agency for Research on Cancer, 2010, Lyon. Available from: http://globocan. iarc.fr (22 october 2010,data last accessed).
2. Siegel, R. et al. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA. Cancer J. Clin., 61, 212-236.
3. Brozek, W. et al. (2009) Mutual associations between malignancy, age, gender, and subsite incidence of colorectal cancer. Anticancer Res., 29, 3721-3726.
4. Hendifar, A. et al. (2009) Gender disparities in metastatic colorectal cancer survival. Clin. Cancer Res., 15, 6391-6397.
5. Koo, J.H. et al. (2008) Improved survival in young women with colorectal cancer. Am. J. Gastroenterol., 103, 1488-1495.
6. Calle, E.E. et al. (1995) Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J. Natl. Cancer Inst., 87, 517-523.
7. Franceschi, S. et al. (2000) Menopause and colorectal cancer. Br. J. Cancer, 82, 1860-1862.
8. Rossouw, J.E. et al.; Writing Group for the Women's Health Initiative Investigators. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controled trail, jama,288,321-333
9. Newcomb, P.A. et al. (2007) Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res., 67, 7534-7539.
10. Lin, K.J. et al. (2012) The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer. Int. J. Cancer, 130, 419-430.
11. Fernandez, E. et al. (2001) Oral contraceptives and colorectal cancer risk: a meta-analysis. Br. J. Cancer, 84, 722-727.
12. Weige, C.C. et al. (2009) Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Res., 69, 9118-9124.
13. Williams, C. et al. (2008) A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene, 27, 1019-1032.
14. Chang, E.C. et al. (2006) Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology, 147, 4831-4842.
15. Foley, E.F. et al. (2000) Selective loss of estrogen receptor beta in malignant human colon. Cancer Res., 60, 245-248.
16. Campbell-Thompson, M. et al. (2001) Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res., 61, 632-640.
17. Konstantinopoulos, P.A. et al. (2003) Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur. J. Cancer, 39, 1251-1258
18. Honma, N. et al. (2013) Estrogen receptor-ß gene polymorphism and colorectal cancer risk: effect modified by body mass index and isoflavone intake. Int. J. Cancer, 132, 951-958.
19. Wu, H. et al. (2012) Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study. BMC Cancer, 12, 276.
20. Passarelli, M.N. et al. (2013) Common single-nucleotide polymorphisms in the estrogen receptor ß promoter are associated with colorectal cancer survival in postmenopausal women. Cancer Res., 73, 767-775.
21. Giroux, V. et al. (2008) Estrogen receptor beta deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice. Int. J. Cancer, 123, 303-311.
22. Giroux, V. et al. (2011) Chemopreventive effect of ERß-Selective agonist on intestinal tumorigenesis in Apc(Min/+) mice. Mol. Carcinog., 50, 359-369.
23. Saleiro, D. et al. (2010) Enhanced induction of mucin-depleted foci in estrogen receptor {beta} knockout mice. Cancer Prev. Res. (Phila)., 3, 1198-1204.
24. Saleiro, D. et al. (2012) Estrogen receptor-ß protects against colitis-associated neoplasia in mice. Int. J. Cancer, 131, 2553-2561.
25. Martineti, V. et al. (2005) ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr. Relat. Cancer, 12, 455-469.
26. Hartman, J. et al. (2009) Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. Cancer Res., 69, 6100-6106.
27. Bielecki, A. et al. (2011) Estrogen receptor-ß mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. Nutr. Cancer, 63, 139-150.
28. Tu, Z. et al. (2012) Estrogen receptor ß potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells. J. Cancer Res. Clin. Oncol., 138, 1091-1103.
29. Edvardsson, K. et al. (2011) Estrogen receptor ß induces antiinflammatory and antitumorigenic networks in colon cancer cells. Mol. Endocrinol., 25, 969-979.
30. Johnson, C.D. et al. (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res., 67, 7713-7722.
31. Friedman, R.C. et al. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 19, 92-105.
32. Calin, G.A. et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A., 101, 2999-3004.
33. Farazi, T.A. et al. (2011) miRNAs in human cancer. J. Pathol., 223, 102-115.
34. Michael, M.Z. et al. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891.
35. Nugent, M. et al. (2011) MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur. J. Surg. Oncol., 37, 649-654.
36. Wu, W.K. et al. (2011) MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis, 32, 247-253.
37. Zhao, C. et al. (2009) A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat. Struct. Mol. Biol., 16, 365-371.
38. Bethke, A. et al. (2009) Nuclear hormone receptor regulation of microRNAs controls developmental progression. Science, 324, 95-98.
39. Shah, Y.M. et al. (2007) Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol. Cell. Biol., 27, 4238-4247.
40. Smith, L.K. et al. (2010) Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis. J. Biol. Chem., 285, 36698-36708.
41. Cochrane, D.R. et al. (2011) Steroid receptors and microRNAs: relationships revealed. Steroids, 76, 1-10.
42. Eendebak, R.J. et al. (2011) Nuclear receptors and microRNAs: who regulates the regulators in neural stem cells? FEBS Lett., 585, 717-722.
43. Bhat-Nakshatri, P. et al. (2009) Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res., 37, 4850-4861.
44. Maillot, G. et al. (2009) Widespread estrogen-dependent repression of microRNAs involved in breast tumor cell growth. Cancer Res., 69, 8332-8340.
45. Castellano, L. et al. (2009) The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc. Natl. Acad. Sci. U.S.A., 106, 15732-15737.
46. Kondo, N. et al. (2008) miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res., 68, 5004-5008.
47. Wickramasinghe, N.S. et al. (2009) Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res., 37, 2584-2595.
48. de Souza Rocha Simonini, P. et al. (2010) Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res., 70, 9175-9184.
49. Di Leva, G. et al. (2010) MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J. Natl. Cancer Inst., 102, 706-721.
50. Xiong, J. et al. (2010) An estrogen receptor alpha suppressor, micro- RNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J., 277, 1684-1694.
51. Katchy, A. et al. (2012) Estradiol-activated estrogen receptor a does not regulate mature microRNAs in T47D breast cancer cells. J. Steroid Biochem. Mol. Biol., 128, 145-153.
52. Klinge, C.M. (2012) miRNAs and estrogen action. Trends Endocrinol. Metab., 23, 223-233.
53. Paris, O. et al. (2012) Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. Oncogene, 31, 4196-4206.
54. Saji, S. et al. (2000) Estrogen receptors alpha and beta in the rodent mammary gland. Proc. Natl. Acad. Sci. U.S.A., 97, 337-342.
55. Grober, O.M. et al. (2011) Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics, 12, 36.
56. Hua, S. et al. (2008) Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol. Syst. Biol., 4, 188.
57. Zhao, C. et al. (2010) Genome-wide mapping of estrogen receptor-betabinding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Res., 70, 5174-5183.
58. Aydogdu, E. et al. (2012) MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. Carcinogenesis, 33, 1502-1511.
59. Esslimani-Sahla, M. et al. (2004) Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. Clin. Cancer Res., 10, 5769-5776.
60. Uhlen, M. et al. (2010) Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol., 28, 1248-1250.
61. Holbeck, S. et al. (2010) Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions. Mol. Endocrinol., 24, 1287-1296.
62. Katzenellenbogen, B.S. et al. (1987) Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res., 47, 4355-4360.
63. Webb, P. et al. (1992) The limits of the cellular capacity to mediate an estrogen response. Mol. Endocrinol., 6, 157-167.
64. Zhang, Z. et al. (2010) Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res., 70, 2379-2388.
65. Wu, P.P. et al. (2009) Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells. Ann. Clin. Lab. Sci., 39, 263-269.
66. Yabuta, N. et al. (2011) The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis. Cell Cycle, 10, 2724-2736.
67. Sivarajasingham, N.S. et al. (2003) Identifying a region of interest in siteand stage-specific colon cancer on chromosome 13. Ann. Surg. Oncol., 10, 1095-1099.
68. Carroll, J.S. et al. (2005) Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell, 122, 33-43.
69. O'Donnell, K.A. et al. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-843.
70. Bui, T.V. et al. (2010) Myc: maestro of microRNAs. Genes Cancer, 1, 568-575.
71. Kim, J.W. et al. (2010) Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate. Cancer Res., 70, 4820-4828.
72. Chang, T.C. et al. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet., 40, 43-50.
73. Ma, L. et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol., 12, 247-256.
74. Lin, C.H. et al. (2009) Myc-regulated microRNAs attenuate embryonic stem cell differentiation. EMBO J., 28, 3157-3170.
75. Diosdado, B. et al. (2009) MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br. J. Cancer, 101, 707-714.
76. Yu, G. et al. (2012) Prognostic values of the miR-17-92 cluster and its paralogs in colon cancer. J. Surg. Oncol., 106, 232-237.
77. He, L. et al. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833.
78. Zhang, J. et al. (2012) miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer. Br. J. Cancer, 107, 352-359.
79. Yang, L. et al. (2012) Sorghum phenolics demonstrate estrogenic action and induce apoptosis in nonmalignant colonocytes. Nutr. Cancer, 64, 419-427.
80. Schleipen, B. et al. (2011) ERß-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine. Carcinogenesis, 32, 1675-1683.
81. Dews, M. et al. (2010) The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res., 70, 8233-8246.
82. Wong, C.W. et al. (2001) Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands. Biochemistry, 40, 6756-6765.
83. Leo, C. et al. (2000) Differential mechanisms of nuclear receptor regulation by receptor-associated coactivator 3. J. Biol. Chem., 275, 5976-5982.
84. Gregory, P.A. et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol., 10, 593-601.
85. Slaby, O. et al. (2009) MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol. Cancer, 8, 102.
86. Panarelli, N.C. et al. (2011) MicroRNA expression in selected carcinomas of the gastrointestinal tract. Patholog. Res. Int., 2011, 124608.
87. Luo, X. et al. (2011) MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol. Biomarkers Prev., 20, 1272-1286.
88. Grivas, P.D. et al. (2009) Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance? Int. J. Colorectal Dis., 24, 613-622.
89. Weige, C.C. et al. (2012) P53 mediates estradiol induced activation of apoptosis and DNA repair in non-malignant colonocytes. J. Steroid Biochem. Mol. Biol., 128, 113-120.
90. Eades, G. et al. (2011) miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J. Biol. Chem., 286, 25992-26002.
91. Hur, K. et al. (2012) MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut. [Epub ahead of print]
92. Xu, X. et al. (2012) Concentration of endogenous estrogens and estrogen metabolites in the NCI-60 human tumor cell lines. Genome Med., 4, 31.